Balance Sheet Yuhan Corporation

Equities

A000100

KR7000100008

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 2024-09-12			5-day change	1st Jan Change
124,800.00 ^KRW	+3.83%		-10.60%	+81.40%

08-22	South Korean Shares Rise After BOK Rate Hold; Yuhan Gains on FDA Approval	MT
08-22	Yuhan Shares Jump 4% After US FDA Approves Anti-Cancer Drug for US Markets	MT

332782f1.J1aqoSBgyze6p-XbL7D32NEa0YXO1rBzEc_24Bszu4I.XQnHwBRTlEHl0IaiAt6hlYdbm7SrofdGZ5CsslBl-bFMZd6TEBCYWcPGkg

Published financial data: YUHAN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	1,480B	1,620B	1,688B	1,776B	1,859B
Other Revenues, Total	-	-10	10	-	-10
Total Revenues	1,480B	1,620B	1,688B	1,776B	1,859B
Cost of Goods Sold, Total	1,050B	1,062B	1,164B	1,259B	1,294B
Gross Profit	430B	557B	523B	517B	565B
Selling General & Admin Expenses, Total	298B	308B	348B	354B	369B
Provision for Bad Debts	351M	1.19B	-1.42B	2.08B	1.42B
R&D Expenses	96.9B	143B	107B	107B	120B
Depreciation & Amortization - (IS)	10.08B	11.39B	11.14B	7.85B	6.83B
Amortization of Goodwill and Intangible Assets - (IS)	2.54B	2.47B	2.41B	1.46B	2.37B
Other Operating Expenses	9.57B	7.17B	7.61B	8.2B	8.69B
Other Operating Expenses, Total	417B	473B	475B	481B	508B
Operating Income	12.54B	84.26B	48.6B	36.03B	56.67B
Interest Expense, Total	-3.1B	-2.71B	-2.94B	-3.47B	-6.3B
Interest And Investment Income	17.24B	6.9B	5.24B	10.27B	13.85B
Net Interest Expenses	14.14B	4.19B	2.3B	6.81B	7.55B
Income (Loss) On Equity Invest.	37.6B	61.12B	75.86B	42.38B	81.37B
Currency Exchange Gains (Loss)	-3.49B	-18.64B	19.65B	19.17B	2.31B
Other Non Operating Income (Expenses)	-1.84B	-21.01B	-7.93B	-6.63B	-12.18B
EBT, Excl. Unusual Items	58.94B	110B	138B	97.75B	136B
Gain (Loss) On Sale Of Investments	899M	2.7B	1.79B	4.11B	3.28B
Gain (Loss) On Sale Of Assets	-2.53M	132B	-624M	180M	132M
Asset Writedown	-4.92B	-4.92B	-13.58B	-7.11B	-4.6B
EBT, Incl. Unusual Items	54.92B	240B	126B	94.93B	135B
Income Tax Expense	18.31B	49.49B	26.93B	4.33B	508M
Earnings From Continuing Operations	36.61B	190B	99.13B	90.59B	134B
Net Income to Company	36.61B	190B	99.13B	90.59B	134B
Minority Interest	3.39B	2.36B	3.46B	4.55B	2.06B
Net Income - (IS)	40.01B	193B	103B	95.14B	136B
Preferred Dividend and Other Adjustments	784M	3.56B	1.73B	1.54B	2.1B
Net Income to Common Incl Extra Items	39.22B	189B	101B	93.61B	134B
Net Income to Common Excl. Extra Items	39.22B	189B	101B	93.61B	134B
Per Share Items
Net EPS - Basic	517.15	2.5K	1.33K	1.19K	1.7K
Basic EPS - Continuing Operations	517.15	2.5K	1.33K	1.19K	1.7K
Basic Weighted Average Shares Outstanding	75.84M	75.74M	75.59M	78.94M	78.71M
Net EPS - Diluted	517.15	2.5K	1.33K	1.19K	1.7K
Diluted EPS - Continuing Operations	517.15	2.5K	1.33K	1.19K	1.7K
Diluted Weighted Average Shares Outstanding	75.84M	75.74M	75.59M	78.94M	78.71M
Normalized Basic EPS	530.5	938.18	1.19K	831.55	1.1K
Normalized Diluted EPS	530.5	938.18	1.19K	831.55	1.1K
Dividend Per Share	329.08	329.08	362.81	362.81	428.57
Payout Ratio	57.27	12.34	24.31	27.41	20.04
Supplemental Items
EBITDA	71.19B	144B	101B	79.05B	101B
EBITA	17.1B	89.04B	54.1B	40.5B	62.88B
EBIT	12.54B	84.26B	48.6B	36.03B	56.67B
Effective Tax Rate - (Ratio)	33.33	20.63	21.37	4.57	0.38
Normalized Net Income	40.23B	71.06B	90B	65.65B	86.88B
Supplemental Operating Expense Items
Advertising Expense	85.48B	78.97B	108B	113B	110B
Selling and Marketing Expenses	134B	130B	163B	173B	176B
General and Administrative Expenses	2.51B	2.04B	2.17B	2.93B	3.31B
Research And Development Expense From Footnotes	96.9B	143B	107B	107B	120B
Maintenance & Repair Expenses, Total	978M	1.04B	1.24B	989M	1.35B
Stock-Based Comp., SG&A Exp. (Total)	-	591M	689M	345M	145M
Total Stock-Based Compensation	-	591M	689M	345M	145M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	274B	353B	254B	293B	299B
Short Term Investments	21.41B	9.99B	47.45B	28.09B	12.35B
Trading Asset Securities, Total	119B	82.12B	136B	26.59B	10.39B
Total Cash And Short Term Investments	415B	446B	437B	348B	322B
Accounts Receivable, Total	397B	443B	461B	497B	559B
Other Receivables	20.68B	21.52B	12.8B	12.44B	14.96B
Notes Receivable	200M	164M	154M	186M	601M
Total Receivables	418B	464B	474B	509B	575B
Inventory	187B	252B	275B	275B	285B
Prepaid Expenses	1.56B	2.3B	5.76B	7.43B	9.28B
Other Current Assets, Total	38.8B	31.24B	32.7B	49.22B	52.62B
Total Current Assets	1,060B	1,196B	1,224B	1,189B	1,243B
Gross Property Plant And Equipment	751B	794B	837B	891B	1,089B
Accumulated Depreciation	-423B	-468B	-506B	-536B	-567B
Net Property Plant And Equipment	327B	326B	331B	355B	523B
Long-term Investments	565B	730B	743B	622B	571B
Goodwill	125M	125M	125M	5.87B	117B
Other Intangibles, Total	25.56B	18.66B	16.25B	28.22B	48.93B
Deferred Tax Assets Long-Term	9.15B	11.23B	10.84B	26.51B	44.25B
Deferred Charges Long-Term	3.04B	39.71B	71.22B	103B	132B
Other Long-Term Assets, Total	126B	72.34B	67.15B	143B	134B
Total Assets	2,117B	2,394B	2,464B	2,473B	2,814B
Liabilities
Accounts Payable, Total	111B	122B	142B	134B	179B
Accrued Expenses, Total	12.26B	3.46B	5.67B	6.01B	9.22B
Short-term Borrowings	15B	48.5B	69B	64.48B	128B
Current Portion of Long-Term Debt	24.02B	20.48B	20.55B	28.33B	37.55B
Current Portion of Leases	2.8B	3.08B	2.59B	1.48B	1.91B
Current Income Taxes Payable	5.42B	28.47B	42.81B	26.62B	9.6B
Other Current Liabilities	182B	156B	150B	173B	218B
Total Current Liabilities	352B	382B	432B	434B	583B
Long-Term Debt	44.25B	46.77B	28.12B	625M	60.23B
Long-Term Leases	5.41B	4.25B	4.5B	2.78B	2.16B
Pension & Other Post Retirement Benefits	11.86B	53.64B	16.92B	1.48B	2.04B
Deferred Tax Liability Non Current	38.33B	41.97B	26.17B	-	952M
Other Non Current Liabilities	15.14B	18.21B	20.23B	25.89B	63.77B
Total Liabilities	467B	547B	528B	465B	712B
Common Stock, Total	65.07B	68.04B	71.15B	74.41B	77.82B
Additional Paid In Capital	112B	114B	112B	116B	114B
Retained Earnings	1,545B	1,691B	1,800B	1,902B	1,975B
Treasury Stock	-174B	-177B	-193B	-210B	-217B
Comprehensive Income and Other	97.43B	143B	136B	103B	101B
Total Common Equity	1,646B	1,840B	1,927B	1,986B	2,051B
Minority Interest	3.73B	6.39B	9.02B	21.98B	50.59B
Total Equity	1,650B	1,847B	1,936B	2,008B	2,102B
Total Liabilities And Equity	2,117B	2,394B	2,464B	2,473B	2,814B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	75.77M	72.15M	75.38M	75.13M	74.98M
ECS Total Common Shares Outstanding	75.77M	72.15M	75.38M	75.13M	74.98M
Book Value / Share	21.73K	25.51K	25.56K	26.43K	27.36K
Tangible Book Value	1,621B	1,821B	1,910B	1,952B	1,885B
Tangible Book Value Per Share	21.39K	25.24K	25.35K	25.98K	25.14K
Total Debt	91.48B	123B	125B	97.69B	230B
Net Debt	-323B	-323B	-312B	-250B	-91.93B
Minority Interest, Total (Incl. Fin. Div)	3.73B	6.39B	9.02B	21.98B	50.59B
Equity Method Investments, Total	407B	528B	614B	532B	489B
Inventories - Raw Materials, Total	42.73B	42.83B	45.89B	58.1B	70.78B
Inventories - Work In Process, Total	45.8B	40.66B	51.81B	42.66B	49.68B
Inventories - Finished Goods, Total	108B	183B	195B	194B	185B
Inventories - Others	-870	-80	440	-120	260
Land - (BS)	70.22B	86.46B	91.3B	91.9B	107B
Buildings, Total	233B	240B	255B	264B	300B
Machinery, Total	430B	460B	480B	502B	530B
Accumulated Allowance for Doubtful Accounts (Supple)	3.89B	5.02B	3.6B	5.65B	7.15B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	40.01B	193B	103B	95.14B	136B
Depreciation & Amortization - CF	54.09B	55B	47.16B	38.55B	38.47B
Amortization of Goodwill and Intangible Assets - (CF)	4.57B	4.79B	5.51B	4.47B	6.21B
Depreciation & Amortization, Total	58.66B	59.78B	52.67B	43.02B	44.68B
(Gain) Loss From Sale Of Asset	-7.32B	-132B	624M	-180M	-132M
(Gain) Loss on Sale of Investments - (CF)	-877M	2.22B	6.64B	-2.05B	54.48M
Asset Writedown & Restructuring Costs	4.9B	-	5.15B	5.06B	1.26B
(Income) Loss On Equity Investments - (CF)	-30.28B	-61.12B	-75.86B	-42.38B	-81.37B
Stock-Based Compensation (CF)	-	-	689M	464M	339M
Provision and Write-off of Bad Debts	351M	1.19B	-1.42B	2.08B	1.33B
Other Operating Activities, Total	64.4B	122B	68.86B	108B	50.27B
Change In Accounts Receivable	-55.42B	-61.17B	-16.92B	-37.34B	-63.42B
Change In Inventories	56.54B	-69.27B	-26.11B	-382M	-5.4B
Change In Accounts Payable	21.31B	11.77B	20.56B	-7.81B	44.51B
Change in Other Net Operating Assets	-86.28B	-37.32B	-38.48B	-64.52B	15.91B
Cash from Operations	65.99B	28.83B	99B	99.53B	144B
Capital Expenditure	-42.76B	-51.45B	-46.15B	-65.8B	-161B
Sale of Property, Plant, and Equipment	325M	372M	178M	23.91M	181M
Divestitures	-70M	-	-	1.94B	12.56B
Sale (Purchase) of Intangible assets	-3.97B	-33.23B	-35.12B	-36.08B	-42.42B
Investment in Marketable and Equity Securities, Total	84.29B	-43.5B	-146B	129B	-53.72B
Net (Increase) Decrease in Loans Originated / Sold - Investing	67.41M	-297M	99M	138M	-83M
Other Investing Activities, Total	-6.27B	186B	59.8B	-13.49B	45.74B
Cash from Investing	31.6B	57.59B	-167B	15.62B	-199B
Short Term Debt Issued, Total	14.5B	33.5B	27B	-	59.5B
Long-Term Debt Issued, Total	-	4.4B	1.9B	-	58.2B
Total Debt Issued	14.5B	37.9B	28.9B	-	118B
Short Term Debt Repaid, Total	-871M	-	-6.5B	-5B	-2.12B
Long-Term Debt Repaid, Total	-49.27B	-8.58B	-23.78B	-25.04B	-29.67B
Total Debt Repaid	-50.14B	-8.58B	-30.28B	-30.04B	-31.79B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-8.4B	-3.12B	-16.42B	-16.46B	-7.46B
Common Dividends Paid	-22.91B	-23.78B	-24.94B	-26.08B	-27.27B
Common & Preferred Stock Dividends Paid	-22.91B	-23.78B	-24.94B	-26.08B	-27.27B
Other Financing Activities, Total	-57.99M	9.27B	6.21B	7.04B	12.07B
Cash from Financing	-67.01B	11.69B	-36.53B	-65.54B	63.25B
Foreign Exchange Rate Adjustments	2.34B	-18.84B	4.77B	-10.16B	-1.92B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	32.92B	79.28B	-99.9B	39.45B	6.22B
Supplemental Items
Cash Interest Paid	3.1B	2.48B	2.71B	3.11B	4.3B
Cash Income Tax Paid (Refund)	35.59B	27.96B	39.16B	66.22B	32.9B
Levered Free Cash Flow	17.69B	-78.26B	-7.04B	-85.73B	-132B
Unlevered Free Cash Flow	19.63B	-76.56B	-5.2B	-83.56B	-128B
Change In Net Working Capital	132M	105B	7.66B	47.56B	4.37B
Net Debt Issued / Repaid	-35.64B	29.32B	-1.38B	-30.04B	85.91B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	0.37	2.33	1.25	0.91	1.34
Return on Total Capital	0.45	2.84	1.51	1.08	1.6
Return On Equity %	2.22	10.89	5.24	4.59	6.52
Return on Common Equity	2.39	10.85	5.35	4.78	6.64
Margin Analysis
Gross Profit Margin %	29.04	34.41	31.01	29.12	30.37
SG&A Margin	20.12	19.03	20.64	19.96	19.83
EBITDA Margin %	4.81	8.89	6	4.45	5.45
EBITA Margin %	1.16	5.5	3.21	2.28	3.38
EBIT Margin %	0.85	5.2	2.88	2.03	3.05
Income From Continuing Operations Margin %	2.47	11.75	5.87	5.1	7.21
Net Income Margin %	2.7	11.9	6.08	5.36	7.32
Net Avail. For Common Margin %	2.65	11.68	5.98	5.27	7.21
Normalized Net Income Margin	2.72	4.39	5.33	3.7	4.67
Levered Free Cash Flow Margin	1.19	-4.83	-0.42	-4.83	-7.1
Unlevered Free Cash Flow Margin	1.33	-4.73	-0.31	-4.71	-6.89
Asset Turnover
Asset Turnover	0.69	0.72	0.69	0.72	0.7
Fixed Assets Turnover